全球栓塞预防装置市场规模、份额、趋势和成长分析报告（2026-2034年）

预计抗栓塞装置（EPD）的市场规模将从 2025 年的 7,571.4 亿美元成长到 2034 年的 15,935.5 亿美元，2026 年至 2034 年的复合年增长率为 8.62%。

抗栓塞装置（EPD）市场正在成长，这主要得益于颈动脉支架置入术和经导管主动脉瓣置换术术（TAVR）等介入心臟病学数量的增加。这些装置有助于防止血管介入过程中碎片进入血液，从而降低中风风险并改善患者预后。人口老化和心血管疾病盛行率上升是推动市场扩张的主要因素。

关键成长要素包括微创心血管手术的进步、设备设计的改进以及支持EPD应用的临床证据不断增加。介入性心臟病专家的认知度提高和监管部门的核准也促进了市场渗透率的提升。专注于提高过滤效率和简化操作的技术创新正在提高EPD的采用率。

随着全球心血管手术数量的持续增长，前景依然乐观。与新一代导管系统的整合以及向周边血管介入领域的拓展，可望拓宽其应用范围。然而，在某些地区，健保报销政策和高成本可能会构成挑战。持续的技术创新和临床检验对于永续发展仍然至关重要。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球栓塞预防器材市场：依产品分类

• 市场分析、洞察与预测
• 远端闭塞装置
• 近端闭塞装置
• 远端滤器

第五章 全球栓塞预防装置市场：依应用领域划分

• 市场分析、洞察与预测
• 心血管疾病
• 神经血管疾病
• 週边血管疾病

第六章 全球栓塞预防设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院和诊所
• 门诊手术中心
• 其他的

第七章 全球栓塞预防器材市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • InspireMDInc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic Plc
  • Cardinal Health
  • Contego Medical, LLC
  • Silk Road MedicalInc
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology

The Embolic Protection Devices Market size is expected to reach USD 1593.55 Billion in 2034 from USD 757.14 Billion (2025) growing at a CAGR of 8.62% during 2026-2034.

The embolic protection devices (EPD) market has grown due to increasing cardiovascular interventions, particularly in procedures such as carotid artery stenting and transcatheter aortic valve replacement (TAVR). These devices help prevent debris from entering the bloodstream during vascular interventions, reducing stroke risk and improving patient outcomes. Aging populations and rising prevalence of cardiovascular diseases have significantly contributed to market expansion.

Key growth drivers include advancements in minimally invasive cardiac procedures, improved device designs, and growing clinical evidence supporting EPD use. Increased awareness among interventional cardiologists and supportive regulatory approvals have also strengthened market penetration. Technological innovations focusing on better filtration efficiency and ease of deployment have enhanced adoption rates.

Future prospects are favorable as cardiovascular procedure volumes continue to rise globally. Integration with next-generation catheter systems and expansion into peripheral vascular interventions may broaden application scope. However, reimbursement policies and high device costs may present challenges in some regions. Continued innovation and clinical validation will remain central to sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Distal Occlusion Devices
• Proximal Occlusion Devices
• Distal Filters

By Application

• Cardiovascular Diseases
• Neurovascular Diseases
• Peripheral Vascular Diseases
• By-End-User
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

COMPANIES PROFILED

• InspireMD, Inc, Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc, Edwards Lifesciences Corporation, Lepu Medical Technology

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Distal Occlusion Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Proximal Occlusion Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Distal Filters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Peripheral Vascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY BY-END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast By-end-user
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By By-end-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By By-end-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By By-end-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By By-end-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By By-end-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EMBOLIC PROTECTION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 InspireMDInc
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 Medtronic Plc
  • 9.2.5 Cardinal Health
  • 9.2.6 Contego Medical, LLC
  • 9.2.7 Silk Road MedicalInc
  • 9.2.8 Edwards Lifesciences Corporation
  • 9.2.9 Lepu Medical Technology